Replies to post #260766 on SwingTrade Member Forum (SWING)

[MikeDDKing]

I added more shares of RX.V / BIOYF at C$1.07 and am bidding for more. I'm putting money where my mouth is.

I think you are underestimating how much growth that RX.V will see next year. Remember 5 products vs. 1. Also, people look at both top line and bottom line. Finally, how many companies can you find with this track record of long term revenue growth? The only other companies that I would put in the same category as RX.V are PFHO, PBSV, and INX.V.

[MikeDDKing]

There were more insider buys on RX.V / BIOYF reported yesterday. A total of 23,676 shares were purchase. The transactions included 16,478 shares purchased at C$1.19 and 7,198 shares purchased at C$1.25. Note that these prices are considerably higher than the last trade of C$1.07.

http://www.canadianinsider.com/node/7?menu_tickersearch=rx